Our Bureau

Hyderabad, July 21

AUROBINDO Pharma Ltd has announced that it has been granted the Certificate of Suitability (CoS) of monographs of the European Pharmacopoeia by the European Directorate for the Quality of Medicines (EDQM) for its active pharmaceutical ingredients (APIs) - domperidone and domperidone maleate.

Domperidone is a commonly used product in gastrointestinal disorders like vomiting.

The company said it has started receiving approvals to penetrate the European market. It has filed several drug master files (DMFs), CoSs and formulation dossiers with various applicable authorities in Europe for its product range.

With the latest endorsement of EDQM, the company said it would be able to sell the products in the whole of Europe.

The stock is currently hovering at Rs 350 on both BSE and NSE.

(This article was published in the Business Line print edition dated July 22, 2005)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.